Key Highlights: Implications: Sun Pharma’s acquisition of Innovcare looks like a portfolio-building move in India: for about ₹271.2 crore, Sun is buying a growing busin...
Key Highlights: Implications: CORONA Remedies is using the Wokadine acquisition to buy its way into India’s ₹648 crore povidone-iodine market with a #2-ranked, 46‑year-old antise...
